What is Intellimed?
Since its inception in 1983, Intellimed has established itself as a cornerstone provider of high-fidelity healthcare data and actionable market insights. The company specializes in bridging the gap between raw clinical information and business intelligence, enabling hospitals and healthcare providers to optimize patient outcomes and operational efficiency. By leveraging deep expertise in physician behavior analysis and market research, Intellimed maintains a competitive moat, serving as a critical partner for the nation's leading healthcare institutions. Their commitment to personalized service and data accuracy has solidified their reputation as a reliable authority in a rapidly digitizing industry.
How much funding has Intellimed raised?
Intellimed has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Intellimed
PPP
Public-Private Partnership
What's next for Intellimed?
With this late-stage capital injection, Intellimed is well-positioned to accelerate its digital transformation initiatives and expand its footprint in the healthcare analytics market. The strategic focus will likely shift toward integrating advanced predictive modeling and real-time data processing capabilities to meet the evolving demands of hospital administrators. By capitalizing on its long-standing industry relationships and deep domain knowledge, the company is poised to reinforce its market leadership, potentially exploring inorganic growth opportunities or further technological diversification to maintain its trajectory of sustained business results.
See full Intellimed company page
